# Heidi M. Crane

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/heidi-m-crane/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,770 |
| Field | HIV/AIDS Research and Interventions |
| h-index | 61 |
| i10-index | 224 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5050408475 |
| ORCID iD | https://orcid.org/0000-0002-3308-7005 |
| Works | 468 |

## Researcher papers

- [HIV Infection and the Risk of Acute Myocardial Infarction](https://scholariq.org/papers/hiv-infection-and-the-risk-of-acute-myocardial-infarction/)
- [Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies](https://scholariq.org/papers/survival-of-hiv-positive-patients-starting-antiretroviral-therapy-between-1996/)
- [Self-report measures of medication adherence behavior: recommendations on optimal use](https://scholariq.org/papers/self-report-measures-of-medication-adherence-behavior-recommendations-on-optimal/)
- [Olanzapine Versus Lithium in the Maintenance Treatment of Bipolar Disorder: A 12-Month, Randomized, Double-Blind, Controlled Clinical Trial](https://scholariq.org/papers/olanzapine-versus-lithium-in-the-maintenance-treatment-of-bipolar-disorder-a-12/)
- [Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada](https://scholariq.org/papers/weight-gain-among-treatment-naive-persons-with-hiv-starting-integrase-inhibitors/)
- [The Role of Technical Advances in the Adoption and Integration of Patient-reported Outcomes in Clinical Care](https://scholariq.org/papers/the-role-of-technical-advances-in-the-adoption-and-integration-of-patient/)
- [Multimorbidity Patterns in HIV-Infected Patients](https://scholariq.org/papers/multimorbidity-patterns-in-hiv-infected-patients/)

## Researcher topics

- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [HIV-related health complications and treatments](https://scholariq.org/topics/hiv-related-health-complications-and-treatments/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [HIV, Drug Use, Sexual Risk](https://scholariq.org/topics/hiv-drug-use-sexual-risk/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.